Scientists Finding Evidence Of Caloric Restriction's Benefits

Sidebar: For More Information - Caloric Restriction's Benefits Caloric restriction (CR) research has come a long way since Cornell University nutritionist Clyde McCay published a ground-breaking 1935 paper that showed that rats on calorically restricted, nutritionally sound diets lived longer than rats that were allowed to eat as much as they wanted (C.J. McCay, Journal of Nutrition, 10:63-79, 1935). Some 50 years of research since has confirmed that finding. In general, experimental animals fe

Written byPaul Mccarthy
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Sidebar: For More Information - Caloric Restriction's Benefits

Today, the National Institute on Aging (NIA) supports CR research in both rodents and primates to the tune of $3 million per year. Much of the rodent work is directed at discovering the mechanism that underlies CR, while the primate studies are showing that CR lowers blood sugar, eliminates diabetes, lowers cholesterol, and reduces blood pressure in genetically susceptible animals. This confirms previous findings in rodent studies and is leading some researchers to believe that eventually CR will be a means of extending maximum life span and retarding chronic disease in humans.

DEFINED FOCUS: "As an institute, our underlying interest is to understand the mechanism, not to produce longer-lived individuals," says NIA's Richard Sprott Before NIA's involvement, "CR research was a semi-joke" because studies were often poorly controlled, contends NIA associate director Richard Sprott. Investigators used different strains of rats on different ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies